mailed
on 19 Dec 2022
Last Applicant/ Owned by
Innovation Way, Heslington YORK YO10 5NY
GB
Serial Number
79339791 filed on 29th Jun 2021
Registration Number
N/A
Correspondent Address
Charles J. Meyer
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Research and development services in the field of medical diagnostics and medical testing; product design and development of diagnostic apparatus, instruments, equipment, tools and devices; product research, design and development in the field of diagnostic preparations; product research, design and development of reagents; product research, design and development of aptamer reagents; product reseRead More
Medical, veterinary and diagnostic services, namely, medical testing for diagnostic or treatment purposes, virus testing for medical diagnostic or treatment purposes, veterinary testing for diagnostic or treatment purposes; medical and veterinary testing services, namely, genetic testing for medical, diagnostic and treatment purposes, veterinary testing for diagnostic or treatment purposes; medical and veterinary testing for diagnostic or treatment purposes; medical and veterinary analysis services for diagnostic and treatment purposes, namely, medical analysis for the diagnosis and treatment of persons, medical analysis for the diagnosis and treatment of animals; medical and veterinary testing services relating to diagnosis and treatment; medical and veterinary analysis services, namely, medical analysis for the diagnosis and treatment of persons, medical analysis for the diagnosis and treatment of animals; information and advisory services in respect of the aforementioned services
Research and development services in the field of medical diagnostics and medical testing; product design and development of diagnostic apparatus, instruments, equipment, tools and devices; product research, design and development in the field of diagnostic preparations; product research, design and development of reagents; product research, design and development of aptamer reagents; product research, design and development of aptamer reagents for integration into diagnostic platforms; product research, design and development of reagents for therapeutic applications; product research, design and development of aptamer reagents for therapeutic applications; custom product development of reagents; custom product development of aptamer reagents; medical research, namely, optimsation of aptamer molecules; product research, design and development of nucleic acids for medical, veterinary, diagnostic and pharmaceutical purposes; product research, design and development of nucleic acid sequences for medical, veterinary, diagnostic and pharmaceutical purposes laboratory testing services, namely, testing of pharmaceuticals; medical and scientific laboratory services for analytical testing; design and development of testing and analysis methods, namely, research and development of advanced learning technologies and teaching methods; medical and scientific laboratory services, namely, preparation of biological samples for testing and analysis in research laboratories; medical and veterinary research services; medical and veterinary laboratory services; scientific research and investigations for medical and veterinary purposes; medical and scientific laboratory services, namely, analysis of human and animal tissues and samples for medical and veterinary research; biological research, clinical research, medical research and veterinary research in the field of medical diagnostics and medical testing; provision of information and data relating to medical and veterinary research and development; information and advisory services in respect of the aforementioned services
Reagents for medical use; chemical reagents for medical use; medical, veterinary, clinical, diagnostic and pharmaceutical reagents, agents, chemicals, materials, substances and preparations, namely, clinical medical reagents, reagents for medical use, veterinary diagnostic reagents, chemical reagents for medical purposes, diagnostic agents, preparations and substances for medical purposes; optimised aptamer molecules for medical and veterinary use, namely, veterinary diagnostic reagents, chemical reagents for medical purposes, diagnostic media for bacteriological cultures; medical and veterinary diagnostic reagents and assays for testing of body fluids; medical and veterinary diagnostic test strips for the analysis of blood, urine, saliva, human tissue and animal tissue; diagnostic biomarker reagents for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic or treatment purposes, namely, diagnostic reagents and contrast media for medical use; nucleic acids for medical, veterinary, diagnostic and pharmaceutical purposes, namely, nucleic acids being diagnostic reagents and chemical reagents for medical and veterinary purposes; nucleic acid sequences for medical, veterinary, diagnostic and pharmaceutical purposes; diagnostic testing kits comprised of medical diagnostic reagents, assays, monoclonal antibodies, buffers and reagents for testing of bodily fluids, human tissue and animal tissue for use in disease detection; diagnostic reagents for medical and veterinary use for sale in kit form; diagnostic kits comprising specimen receptors and reagents for medical, veterinary and diagnostic testing in the nature of diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids, human tissue and animal tissue for use in disease detection; medical and veterinary diagnostic reagents and assays for testing of fluids
No 79339791
No Service Mark
No 34771-2
No
No
No
No
Yes
Yes
No
No
The mark consists of the word "OPTIMER" in a stylized font.
| Status Date | Action Taken |
|---|---|
| 31st Oct 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 11th Oct 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 11th Oct 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 19th Dec 2022 | EXAMINERS AMENDMENT -WRITTEN |
| 19th Dec 2022 | EXAMINERS AMENDMENT E-MAILED |
| 19th Dec 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 16th Dec 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 15th Dec 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 15th Dec 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 06th Jul 2022 | REFUSAL PROCESSED BY IB |
